Cargando…
Refractory celiac disease and its mimickers: a review on pathogenesis, clinical-pathological features and therapeutic challenges
Refractory celiac disease (RCD) and enteropathy-associated T-cell lymphoma (EATL) are rare, yet severe complications of celiac disease (CD). Over the last decades, several studies have addressed the biology and clinical-pathological features of such conditions, highlighting unique disease patterns a...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662059/ https://www.ncbi.nlm.nih.gov/pubmed/38023263 http://dx.doi.org/10.3389/fonc.2023.1273305 |
_version_ | 1785138123001298944 |
---|---|
author | Scarmozzino, Federico Pizzi, Marco Pelizzaro, Filippo Angerilli, Valentina Dei Tos, Angelo Paolo Piazza, Francesco Savarino, Edoardo Vincenzo Zingone, Fabiana Fassan, Matteo |
author_facet | Scarmozzino, Federico Pizzi, Marco Pelizzaro, Filippo Angerilli, Valentina Dei Tos, Angelo Paolo Piazza, Francesco Savarino, Edoardo Vincenzo Zingone, Fabiana Fassan, Matteo |
author_sort | Scarmozzino, Federico |
collection | PubMed |
description | Refractory celiac disease (RCD) and enteropathy-associated T-cell lymphoma (EATL) are rare, yet severe complications of celiac disease (CD). Over the last decades, several studies have addressed the biology and clinical-pathological features of such conditions, highlighting unique disease patterns and recurrent genetic events. Current classification proposals identify two forms of RCD, namely: (i) type 1 RCD (RCD-I), characterized by phenotypically normal intra-epithelial lymphocytes (IELs); and (ii) type 2 RCD (RCD-II), featuring phenotypically aberrant IELs. While RCD-I likely represents a gluten-independent dysimmune reaction against small bowel epithelial cells, RCD-II is better considered an in situ aggressive T-cell lymphoma, with high rates of progression to overt EATL. The diagnosis of RCD and EATL is often challenging, due to misleading clinical-pathological features and to significant overlap with several CD-unrelated gastro-intestinal disorders. Similarly, the treatment of RCD and EATL is an unmet clinical need for both gastroenterologists and hematologists. Moving from such premises, this review aims to provide a comprehensive view of RCD and EATL, specifically considering their pathogenesis and the many still open issues concerning their diagnosis and clinical management. |
format | Online Article Text |
id | pubmed-10662059 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-106620592023-01-01 Refractory celiac disease and its mimickers: a review on pathogenesis, clinical-pathological features and therapeutic challenges Scarmozzino, Federico Pizzi, Marco Pelizzaro, Filippo Angerilli, Valentina Dei Tos, Angelo Paolo Piazza, Francesco Savarino, Edoardo Vincenzo Zingone, Fabiana Fassan, Matteo Front Oncol Oncology Refractory celiac disease (RCD) and enteropathy-associated T-cell lymphoma (EATL) are rare, yet severe complications of celiac disease (CD). Over the last decades, several studies have addressed the biology and clinical-pathological features of such conditions, highlighting unique disease patterns and recurrent genetic events. Current classification proposals identify two forms of RCD, namely: (i) type 1 RCD (RCD-I), characterized by phenotypically normal intra-epithelial lymphocytes (IELs); and (ii) type 2 RCD (RCD-II), featuring phenotypically aberrant IELs. While RCD-I likely represents a gluten-independent dysimmune reaction against small bowel epithelial cells, RCD-II is better considered an in situ aggressive T-cell lymphoma, with high rates of progression to overt EATL. The diagnosis of RCD and EATL is often challenging, due to misleading clinical-pathological features and to significant overlap with several CD-unrelated gastro-intestinal disorders. Similarly, the treatment of RCD and EATL is an unmet clinical need for both gastroenterologists and hematologists. Moving from such premises, this review aims to provide a comprehensive view of RCD and EATL, specifically considering their pathogenesis and the many still open issues concerning their diagnosis and clinical management. Frontiers Media S.A. 2023-11-07 /pmc/articles/PMC10662059/ /pubmed/38023263 http://dx.doi.org/10.3389/fonc.2023.1273305 Text en Copyright © 2023 Scarmozzino, Pizzi, Pelizzaro, Angerilli, Dei Tos, Piazza, Savarino, Zingone and Fassan https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Scarmozzino, Federico Pizzi, Marco Pelizzaro, Filippo Angerilli, Valentina Dei Tos, Angelo Paolo Piazza, Francesco Savarino, Edoardo Vincenzo Zingone, Fabiana Fassan, Matteo Refractory celiac disease and its mimickers: a review on pathogenesis, clinical-pathological features and therapeutic challenges |
title | Refractory celiac disease and its mimickers: a review on pathogenesis, clinical-pathological features and therapeutic challenges |
title_full | Refractory celiac disease and its mimickers: a review on pathogenesis, clinical-pathological features and therapeutic challenges |
title_fullStr | Refractory celiac disease and its mimickers: a review on pathogenesis, clinical-pathological features and therapeutic challenges |
title_full_unstemmed | Refractory celiac disease and its mimickers: a review on pathogenesis, clinical-pathological features and therapeutic challenges |
title_short | Refractory celiac disease and its mimickers: a review on pathogenesis, clinical-pathological features and therapeutic challenges |
title_sort | refractory celiac disease and its mimickers: a review on pathogenesis, clinical-pathological features and therapeutic challenges |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662059/ https://www.ncbi.nlm.nih.gov/pubmed/38023263 http://dx.doi.org/10.3389/fonc.2023.1273305 |
work_keys_str_mv | AT scarmozzinofederico refractoryceliacdiseaseanditsmimickersareviewonpathogenesisclinicalpathologicalfeaturesandtherapeuticchallenges AT pizzimarco refractoryceliacdiseaseanditsmimickersareviewonpathogenesisclinicalpathologicalfeaturesandtherapeuticchallenges AT pelizzarofilippo refractoryceliacdiseaseanditsmimickersareviewonpathogenesisclinicalpathologicalfeaturesandtherapeuticchallenges AT angerillivalentina refractoryceliacdiseaseanditsmimickersareviewonpathogenesisclinicalpathologicalfeaturesandtherapeuticchallenges AT deitosangelopaolo refractoryceliacdiseaseanditsmimickersareviewonpathogenesisclinicalpathologicalfeaturesandtherapeuticchallenges AT piazzafrancesco refractoryceliacdiseaseanditsmimickersareviewonpathogenesisclinicalpathologicalfeaturesandtherapeuticchallenges AT savarinoedoardovincenzo refractoryceliacdiseaseanditsmimickersareviewonpathogenesisclinicalpathologicalfeaturesandtherapeuticchallenges AT zingonefabiana refractoryceliacdiseaseanditsmimickersareviewonpathogenesisclinicalpathologicalfeaturesandtherapeuticchallenges AT fassanmatteo refractoryceliacdiseaseanditsmimickersareviewonpathogenesisclinicalpathologicalfeaturesandtherapeuticchallenges |